Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Manganelli

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
European Heart Journal|July 24, 2001
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathyC Briguori, S Betocchi, F Manganelli, et al.
European Journal of Neurology|September 21, 2020
Diffuse brain connectivity changes in Charcot-Marie-Tooth type 1a patients: a resting-state functional magnetic resonance imaging studyG Pontillo, S Tozza, T Perillo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 20, 2012
The effects of prolonged cathodal direct current stimulation on the excitatory and inhibitory circuits of the ipsilateral and contralateral motor cortexV Di Lazzaro, F Manganelli, M Dileone, et al.
The American Journal of Cardiology|August 15, 1996
Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathyS Betocchi, F Piscione, A Losi M, et al.
European Journal of Neurology|May 11, 2016
Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of lifeL Padua, C Pazzaglia, D Pareyson, et al.
Neuromuscular Disorders : NMD|November 4, 2015
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical courseI Pezzini, A Geroldi, S Capponi, et al.
European Journal of Neurology|July 15, 2016
Nerve conduction velocity in CMT1A: what else can we tell?F Manganelli, C Pisciotta, M M Reilly, et al.
European Journal of Neurology|August 1, 2015
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth diseaseG Piscosquito, M M Reilly, A Schenone, et al.
Journal of Neurology|March 18, 2016
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic areaA Cortese, G Vita, M Luigetti, et al.
Orphanet Journal of Rare Diseases|December 15, 2020
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensusM Grandis, L Obici, M Luigetti, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Heart Journal|July 24, 2001
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathyC Briguori, S Betocchi, F Manganelli, et al.
European Journal of Neurology|September 21, 2020
Diffuse brain connectivity changes in Charcot-Marie-Tooth type 1a patients: a resting-state functional magnetic resonance imaging studyG Pontillo, S Tozza, T Perillo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 20, 2012
The effects of prolonged cathodal direct current stimulation on the excitatory and inhibitory circuits of the ipsilateral and contralateral motor cortexV Di Lazzaro, F Manganelli, M Dileone, et al.
The American Journal of Cardiology|August 15, 1996
Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathyS Betocchi, F Piscione, A Losi M, et al.
European Journal of Neurology|May 11, 2016
Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of lifeL Padua, C Pazzaglia, D Pareyson, et al.
Neuromuscular Disorders : NMD|November 4, 2015
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical courseI Pezzini, A Geroldi, S Capponi, et al.
European Journal of Neurology|July 15, 2016
Nerve conduction velocity in CMT1A: what else can we tell?F Manganelli, C Pisciotta, M M Reilly, et al.
European Journal of Neurology|August 1, 2015
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth diseaseG Piscosquito, M M Reilly, A Schenone, et al.
Journal of Neurology|March 18, 2016
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic areaA Cortese, G Vita, M Luigetti, et al.
Orphanet Journal of Rare Diseases|December 15, 2020
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensusM Grandis, L Obici, M Luigetti, et al.
Pageof 8